AI Image
Scientists Testing Potential Alzheimer's Drug Make Unexpected Discovery
Yahoo • • health
Key Points:
- Russian scientists discovered that the peptide HAEE, previously synthetically engineered to treat Alzheimer's, naturally occurs in the human body and is significantly reduced in Alzheimer's patients.
- HAEE forms a stable complex with amyloid-beta, preventing its aggregation, which is linked to Alzheimer's disease development through plaque formation and neural cell death.
- The finding suggests HAEE could serve as both a biomarker for Alzheimer's diagnosis and a potential treatment by compensating for its deficiency in patients.
- Experts emphasize the need for independent confirmation of HAEE's natural presence and further investigation into its production mechanism and role in disease progression.
- This discovery supports approaches targeting amyloid-beta aggregation while highlighting the importance of considering the body's overall biological system and immunity in Alzheimer's treatment strategies.
